LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Omnicell Inc

Отворен

СекторЗдравеопазване

32.77 2.34

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

32.02

Максимум

32.79

Ключови измерители

By Trading Economics

Приходи

13M

5.6M

Продажби

21M

291M

P/E

Средно за сектора

66.18

35.724

EPS

-0.151

Марж на печалбата

1.941

Служители

3,650

EBITDA

42M

30M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+30.06% upside

Дивиденти

By Dow Jones

Следващи печалби

29.10.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

162M

1.5B

Предишно отваряне

30.43

Предишно затваряне

32.77

Настроения в новините

By Acuity

50%

50%

167 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Omnicell Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.09.2025 г., 23:07 ч. UTC

Придобивния, сливания и поглъщания

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2.09.2025 г., 22:10 ч. UTC

Значими двигатели на пазара

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2.09.2025 г., 21:47 ч. UTC

Печалби

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2.09.2025 г., 16:52 ч. UTC

Значими двигатели на пазара

CleanCore Solutions Shares Drop After $175 Million Private Investment

2.09.2025 г., 22:47 ч. UTC

Пазарно говорене

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2.09.2025 г., 21:40 ч. UTC

Придобивния, сливания и поглъщания

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2.09.2025 г., 21:07 ч. UTC

Печалби

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2.09.2025 г., 21:07 ч. UTC

Печалби

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q Rev $17.35B >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q Adj EPS 78c >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q EPS 82c >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q Net $782.5M >ATD.T

2.09.2025 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

2.09.2025 г., 20:53 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2.09.2025 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.09.2025 г., 20:27 ч. UTC

Печалби

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2.09.2025 г., 20:24 ч. UTC

Придобивния, сливания и поглъщания

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2.09.2025 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2.09.2025 г., 20:17 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2.09.2025 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2.09.2025 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2.09.2025 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2.09.2025 г., 19:55 ч. UTC

Печалби

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2.09.2025 г., 19:50 ч. UTC

Придобивния, сливания и поглъщания

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2.09.2025 г., 19:09 ч. UTC

Пазарно говорене

Oil Futures Gain on Geopolitical Premium -- Market Talk

2.09.2025 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2.09.2025 г., 18:12 ч. UTC

Пазарно говорене

Gold Pushes To New Record -- Market Talk

2.09.2025 г., 17:04 ч. UTC

Пазарно говорене

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2.09.2025 г., 16:57 ч. UTC

Придобивния, сливания и поглъщания

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Omnicell Inc Прогноза

Ценова цел

By TipRanks

30.06% нагоре

12-месечна прогноза

Среден 41.75 USD  30.06%

Висок 55 USD

Нисък 32 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Omnicell Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

4

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

24.23 / 30.44Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

167 / 371 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.